Evidence map›Paper›PMID 41613259›Full record

ArticleFrontiers in neuroscience2025

Rethinking ADHD as a neurointestinal syndrome: a gut-brain-parasite hypothesis.

Alexis Demas

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Alexis DemasNeurology Unit, Department of Neurology, Le Havre Hospital, Le Havre, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodevelopmental conditions such as Attention-Deficit/Hyperactivity Disorder (ADHD) are usually framed as brain-based disorders driven by genetics and neurotransmitter imbalance. At the same time, converging evidence implicates the gut-brain axis and intestinal immunity in shaping cognition and behavior. In this Hypothesis and Theory article, I propose that a subset of ADHD and related neurodivergent profiles can be usefully conceptualized as neurointestinal syndromes, emerging from co-evolutionary interactions between the gut microbiota, intestinal parasites, and host immunity. Drawing on data from ADHD, autism spectrum conditions, and migraine, I synthesize evidence for altered microbiota, increased intestinal permeability, and low-grade inflammation in neurodivergent individuals, and discuss how these changes may bias tryptophan metabolism, vagal signaling, and large-scale brain networks. I then explore a speculative evolutionary scenario in which recurrent helminth exposure, historically ubiquitous, acted as a long-term ecological force shaping gut architecture, immunoregulation, and stress responsivity. Chronic parasitic pressure, combined with microbial metabolites and epigenetic imprinting, may have contributed to the emergence of attentional profiles characterized by hypervigilance, novelty seeking, and rapid switching-traits that could have been advantageous in ancestral, pathogen-rich environments but are often maladaptive in modern settings. This framework does not romanticize ADHD nor deny its frequent clinical burden. Rather, it reframes some ADHD phenotypes as possible mismatch syndromes involving the gut-brain axis, generated when an evolutionarily tuned intestinal and immune architecture is placed in sanitized, post-industrial ecologies. Clinically, this perspective supports continued use of established CNS-targeted treatments while motivating complementary research into microbial, barrier, and vagal interventions as potential adjuncts for carefully defined ADHD subgroups.

Indexed as

ADHDgutgut–brain axishelminthmicrobiota

Identifiers

PMID41613259
PMCPMC12847369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.